Apolipoprotein e genotypes in Mexican patients with Parkinson's disease

Disease Markers

Volumn 27, Issue 5, 2009, Pages 225-230

  Gallegos Arreola, Martha Patricia ^a   Figuera, L E ^a   Ortiz, G G ^a   Jimenez Gil F J ^b   Ramirez Vega J ^a   Ruiz Sandoval J L ^c   Puebla Perez A M ^d   Troyo Sanroman, R ^d   Garcia Ortiz J E ^a   Sanchez Corona, J ^a   Zuniga Gonzalez G M ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA DE OCCIDENTE   (Mexico)

^c Hospital Civil Fray Antonio Alcalde   (Mexico)

^d UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; PESTICIDE; SOLVENT;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 77249107568     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/617863     Document Type: Article

References (30)

1. A. Lieberman, Depression in Parkinson's disease - a review, Acta Neurol Scand 113 (2006), 1-8.
2. J.G. Nutt and F. Wooten, Clinical practice. Diagnosis and initial management of Parkinson's disease, N Engl J Med 353 (2005), 1021-1027.
3. R.L. Nussbaum and C.E. Ellis, Alzheimer's disease and Parkinson's disease, N Engl J Med 348 (2003), 1356-1364.
4. A.E. Lang and A.M. Lozano, Parkinson's disease. First of two parts, N Eng J Med 339 (1998), 1044-1053.
5. E. Tolsa, Enfermedad de Parkinson y otros trastornos del movimiento, in: Medicina Interna, F. Rozman, 13 ed., Elsevier press, España, 2001, pp. 1490-1495.
6. R. Krüger, Parkinson disease, genetic types, Orphanet Encyclopedia (2004), 1-9 (avalaible in http://www.orpha.net/ data/patho/GB/uk-Parkinson.pdf).
7. G. Utermann, U. Langenbeck, U. Beisiegel and W. Weber, Genetics of the apolipoprotein E system in man, Am J Hum Genet 32 (1980), 339-347.
8. The French Parkinson's Disease Genetics study group. Apolipoprotein E genotype in familial Parkinson's disease, J Neurol, Neurosurg and Psychiatry 63 (1997), 394-395.
9. I. Genis, A. Fisher and D.M. Michaelson, Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment, J Neurochem 72 (1999), 206-213.
10. H.S. Hoe, J. Freeman and G.W. Rebeck, Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons, Mol Neurodegener 1 (2006), 18.
11. L.E. Cruz and J.L. V́azquez, Prevalencia de algunas enfermedades neuroĺogicas en la ciudad de Tepatitĺan, Jalisco. Ḿexico, Rev Mex de Neurol 3 (2002), 71-76.
12. INEGI. Instituto Nacional de Estad́istica Geograf́ia e Inform ́atica. 2005; Available from: http://www.inegi.gob.mx/ inegi/default.asp. INEGI, 2005.
13. S.A. Miller, D.D. Dykes and H.F. Polesky, A simple salting out procedure for extracting DNA from human nucleated cell, Nucleic Acids Res 16 (1988), 1215.
14. J.E. Hixson and D.T. Vernier, Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhI, J Lipid Res 31 (1990), 545-548.
15. C.J. Sanguinetti, E. Dias and A.G. Simpson, Rapid silver staining and recovery of PCR products separated on polyacrylamide gels, Biotechniques 17 (1994), 914-921.
16. G.M. Souza, N.L. Romano and M.R. Whittle, Efficient mispriming during apolipoprotein E genotyping, J Bras Patol Med Lab 41 (2005), 25-28.
17. I. Cantuti, C. Keller, B. Bouzou, G. Asteris, T.W. Clark, M.P. Frosch and D.G. Standaert, Effects of gender on nigral gene expression and parkinson disease, Neurobiol Dis 26 (2007), 606-614.
18. M. Behari, A.K. Srivastava, R.R. Das and R.M. Pandey, Risk factors of Parkinson's disease in Indian patients, J Neurol Sci 1 (2001), 49-55.
19. F.D. Dick, G. De Palma, A. Ahmadi, N.W. Scott, G.J. Prescott, J. Bennett, S. Semple, S. Dick, C. Counsell, P. Mozzoni, N. Haites, S.B. Wettinger, A. Mutti, M. Otelea, A. Seaton, P. Söderkvist and A. Felice, Geoparkinson study group. Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study, Occup Environ Med 64 (2007), 666-672. (Pubitemid 47488093)
20. J.M. Gorell, E.L. Peterson, B.A. Rybicki and C.C. Johnson, Multiple risk factors for Parkinson's disease, J Neurol Sci 217 (2004), 169-174.
21. B. Jasinska, G. Opala, C.G. Goetz, J.Tustanowski, S. Ochudlo, A. Gorzkowska and J. Tyrpa, Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia, Arch Neurol 64 (2007), 261-265.
22. G.G. Donohoe, A. Salomäki, T. Lehtimäki, K. Pulkki and V. Kairisto, Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis, Clin Chem 45 (1999), 143-146.
23. L. Bĺazquez, D. Otaegui, A. Śaenz, C. Paiśan, J.I. Emparanza, J. Ruiz, F. Moreno, J.F. Mart́i and A. Ĺopez, Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease, Neurosci Lett 406 (2006), 235-239.
24. N. Pankratz, L. Byder, C. Halter, A. Rudolph, C.W. Shults, P.M. Conneally, T. Foroud and W.C. Nichols, Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia, Mov Disord 21 (2006), 45-49.
25. C.M. Tanner, S.M. Goldman, D.A. Aston, R. Ottman, J. Ellenberg, R. Mayeux and J.W. Langston, Smoking and Parkinson's disease in twins, Neurology 58 (2002), 581-588.
26. G.W. Ross, R.D. Abbott, H. Petrovitch, D.M. Morens, A. Grandinetti, K.H. Tung, C.M. Tanner, K.H. Masaki, P.L. Blanchette, J.D. Curb, J.S. Popper and L.R. White, Association of coffee and caffeine intake with the risk of Parkinson disease, JAMA 283 (2000), 2674-2679.
27. D.B. Hancock, E.R. Martin, G.M. Mayhew, J.M. Stajich, R. Jewett, M.A. Stacy, B.L. Scott, J.M. Vance and W.K. Scott, Pesticide exposure and risk of Parkinson's disease: a familybased case-control study, BMC Neurol 8 (2008), 6.
28. F. Kamel and J.A. Hoppin, Association of pesticide exposure with neurologic disfunction and disease, Enviroment Health Perspectives 112 (2004), 950-958.
29. R. Betarbet and J.T. Greenamyre, Parkinson's disease: animal models, Handb Clin Neurol 83 (2007), 265-287.
30. G. Klodowska, B. Jasínska, K. Safranow, M. Boczarska and G. Opala, The role of environmental factors in Parkinson's disease may depend on disease onset age, Neurol Neurochir Pol 39 (2005), 445-450.